The present invention relates, in general, to the treatment of estrogen-dependent diseases and disorders and, in particular, to a method of treating estrogen-dependent cancers, particularly breast cancer, with antiestrogens.
This application is a continuation of Application No. 09/134,146, filed Aug. 14, 1998, now abandoned, which claims priority from Provisional Application No. 60/055,881, filed Aug. 15, 1997 the entire contents of that application being incorporated herein by reference.
